$7.4 Billion is the total value of Paulson & Co.'s 110 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VST | New | VISTRA ENERGY CORP | $193,598,000 | – | 11,530,556 | +100.0% | 2.62% | – |
| AABA | New | ALTABA INC | $145,734,000 | – | 2,675,000 | +100.0% | 1.97% | – |
| VWR | New | VWR CORP | $88,308,000 | – | 2,675,200 | +100.0% | 1.19% | – |
| HZNP | New | HORIZON PHARMA PLC | $58,584,000 | – | 4,935,500 | +100.0% | 0.79% | – |
| HTZGQ | New | HERTZ GLOBAL HLDGS INCput | $29,325,000 | – | 2,550,000 | +100.0% | 0.40% | – |
| XCRA | New | XCERRA CORP | $24,655,000 | – | 2,523,571 | +100.0% | 0.33% | – |
| NEWR | New | NEW RELIC INC | $15,195,000 | – | 353,300 | +100.0% | 0.20% | – |
| DOVA | New | DOVA PHARMACEUTICALS INC | $13,856,000 | – | 621,632 | +100.0% | 0.19% | – |
| BCR | New | BARD C R INC | $13,315,000 | – | 42,122 | +100.0% | 0.18% | – |
| TGNA | New | TEGNA INC | $11,215,000 | – | 778,300 | +100.0% | 0.15% | – |
| CTRP | New | CTRIP COM INTL LTD | $9,329,000 | – | 173,200 | +100.0% | 0.13% | – |
| SPNC | New | SPECTRANETICS CORP | $9,120,000 | – | 237,500 | +100.0% | 0.12% | – |
| HCA | New | HCA HEALTHCARE INC | $7,848,000 | – | 90,000 | +100.0% | 0.11% | – |
| MGI | New | MONEYGRAM INTL INC | $7,520,000 | – | 435,932 | +100.0% | 0.10% | – |
| SA | New | SEABRIDGE GOLD INC | $7,560,000 | – | 700,000 | +100.0% | 0.10% | – |
| AMRI | New | ALBANY MOLECULAR RESH INC | $6,818,000 | – | 314,200 | +100.0% | 0.09% | – |
| CIEIQ | New | COBALT INTL ENERGY INC | $5,060,000 | – | 2,048,595 | +100.0% | 0.07% | – |
| GRFS | New | GRIFOLS S Asp adr rep b nvt | $4,157,000 | – | 196,753 | +100.0% | 0.06% | – |
| WDAY | New | WORKDAY INCcl a | $3,744,000 | – | 38,600 | +100.0% | 0.05% | – |
| BPMC | New | BLUEPRINT MEDICINES CORP | $3,334,000 | – | 65,800 | +100.0% | 0.04% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $1,943,000 | – | 349,500 | +100.0% | 0.03% | – |
| AAPL | New | APPLE INC | $1,771,000 | – | 12,300 | +100.0% | 0.02% | – |
| ENTL | New | ENTELLUS MED INC | $1,701,000 | – | 102,702 | +100.0% | 0.02% | – |
| IMGN | New | IMMUNOGEN INC | $1,630,000 | – | 229,222 | +100.0% | 0.02% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $1,424,000 | – | 111,100 | +100.0% | 0.02% | – |
| RXDX | New | IGNYTA INC | $1,273,000 | – | 123,000 | +100.0% | 0.02% | – |
| PODD | New | INSULET CORP | $1,283,000 | – | 25,000 | +100.0% | 0.02% | – |
| SIEN | New | SIENTRA INC | $776,000 | – | 79,800 | +100.0% | 0.01% | – |
| HUN | New | HUNTSMAN CORP | $336,000 | – | 13,000 | +100.0% | 0.01% | – |
| OKTA | New | OKTA INCcl a added | $171,000 | – | 7,500 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2017-09-20
About Paulson & Co.
Paulson & Co. is a New York-based investment management firm founded by John Paulson in 1994. The firm is known for its expertise in event-driven investing, which involves taking advantage of market inefficiencies created by corporate events such as mergers, acquisitions, bankruptcies, and spin-offs. Paulson & Co. manages approximately $9 billion in assets and has a team of over 100 professionals.
John Paulson, the founder and CEO of Paulson & Co., is a renowned hedge fund manager who made a fortune by betting against the subprime mortgage market in 2007. He is considered one of the most successful investors of his generation, with a net worth of over $4 billion. Paulson is actively involved in the management of the firm and oversees the investment strategy.
Paulson & Co. has a strong track record of generating high returns for its investors. The firm's flagship fund, the Paulson Advantage Fund, has delivered an average annual return of 12.5% since its inception in 1994. The fund has also outperformed the S&P 500 index in 16 out of the past 22 years.
In recent years, Paulson & Co. has faced some challenges, including a decline in assets under management and a series of high-profile losses. However, the firm has remained committed to its investment philosophy and has continued to generate strong returns for its investors. With a talented team of professionals and a proven track record of success, Paulson & Co. is well-positioned to continue delivering value to its clients in the years ahead.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NOVAGOLD RESOURCES INC | 42 | Q3 2023 | 12.0% |
| INTERNATIONAL TOWER HILL MINE | 42 | Q3 2023 | 3.4% |
| IAMGOLD CORP | 42 | Q3 2023 | 0.5% |
| ANGLOGOLD ASHANTI-SPON ADR | 41 | Q2 2023 | 7.9% |
| AGNICO EAGLE MINES LTD | 34 | Q3 2023 | 3.8% |
| SPDR GOLD TRUST | 33 | Q1 2022 | 13.3% |
| TRILOGY METALS INC NEW | 29 | Q3 2023 | 0.9% |
| ENDO INTL PLC | 28 | Q2 2022 | 3.4% |
| CAESARS ENTMT CORP | 27 | Q4 2019 | 4.6% |
| TIM PARTICIPACOES SA-ADR | 26 | Q3 2020 | 2.4% |
View Paulson & Co.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Thryv Holdings, Inc. | February 14, 2023 | 2,000,000 | 5.8% |
| Endo International plc | February 14, 2022 | 17,327,012 | 7.4% |
| BrightSphere Investment Group Inc. | December 22, 2021 | 8,950,121 | 19.8% |
| PERPETUA RESOURCES CORP. | August 27, 2021 | 20,929,280 | 33.3% |
| Bausch Health Companies Inc. | May 15, 2020 | 25,839,035 | 7.3% |
| OVERSEAS SHIPHOLDING GROUP INC | April 13, 2020 | 6,300,000 | 7.3% |
| SYNTHESIS ENERGY SYSTEMS INC | February 14, 2020 | 165,648 | 10.5% |
| Callon Petroleum Co | November 18, 2019 | 10,338,663 | 4.5% |
| International Seaways, Inc. | July 03, 2019 | 1,459,119 | 5.0% |
| AKORN INCSold out | February 14, 2018 | 0 | 0.0% |
View Paulson & Co.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-01-22 |
| SC 13D/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View Paulson & Co.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.